Dermal–epidermal junction protein expression

The dermal-epidermal junction (DEJ) is a specialized basement membrane that anchors the epidermis to the underlying dermis, providing essential mechanical support and facilitating the exchange of nutrients and signaling molecules (Source: StatPearls, Histology, Dermis). It is composed of a complex network of proteins, including Type IV collagen, Type VII collagen (anchoring fibrils), laminin-332, and nidogen, which together maintain the structural integrity of the skin (Source: Journal of Cell Science, The dermal-epidermal junction). "Dermal-epidermal junction protein expression" refers to the biological process of synthesizing these components, which is a key indicator of skin health and youthfulness. In aging and photoexposed skin, the expression of these proteins decreases, leading to a flattening of the junction and increased skin fragility (Source: PubMed, PMID: 19467015). While not a single molecular target, it is a primary therapeutic endpoint for anti-aging treatments and wound-healing therapies. Pathological deficiencies in specific DEJ proteins, such as Collagen VII, are the underlying cause of severe blistering diseases like epidermolysis bullosa (Source: NIH, National Institute of Arthritis and Musculoskeletal and Skin Diseases). Drugs such as topical retinoids and various bioactive peptides are used to stimulate the production of these proteins to restore skin architecture and improve barrier function.

Other names

DEJ protein expressionBasement membrane zone protein expressionDermal-epidermal junction integrity

Upregulation of mRNA expression and protein synthesis of structural components (e.g., Collagen VII, Laminin-332) by dermal fibroblasts and basal keratinocytes.